Yann Simon
About Yann Simon
Yann Simon is the Sr Director of EXM Quality Bio Sterile GCH at Bristol Myers Squibb in Switzerland, with extensive experience in quality assurance and compliance within the pharmaceutical and biotech industries.
Current Role
Yann Simon is currently working as the Sr Director, EXM Quality Bio Sterile GCH at Bristol Myers Squibb based in Switzerland. In this role, he oversees quality assurance and compliance for biotech and sterile product operations.
Previous Positions
Yann Simon has an extensive career in quality assurance across various esteemed pharmaceutical companies. He previously worked at Ferring Pharmaceuticals in multiple senior roles, including Group Head GQA Supply Chain, External Manufacturing, and Commercial Affiliates Quality Compliance from 2013 to 2019. He also served as the Vice-President, Head of Quality at FerGene from 2020 to 2021 and Head of Quality Adstiladrin at Ferring Pharmaceuticals within the same time frame.
Experience in Quality Management
Yann Simon has a robust background in quality management, particularly in the pharmaceutical and biotech industries. His expertise includes quality assurance for gene therapy products, external manufacturing, and commercial affiliates. He has managed quality initiatives in diverse international locations, including Switzerland, the United States, and the United Kingdom.
Educational Background
Yann Simon holds both a Master's and a Doctorate degree from Université Grenoble Alpes. He completed his Master’s studies in 2001 and his Doctorate in 2001, providing a solid academic foundation for his extensive career in quality assurance and compliance.
Early Career and Specialized Roles
Earlier in his career, Yann Simon worked in specialized roles such as Quality Assurance Compliance Supervisor at Merck Serono and Research Scientist at Pfizer Pharmaceuticals. He also served as Validation Manager at Bracco Research focused on pilot plant development and was a Validation Representative at Aventis Pharmaceuticals.